Conversant provides human cancer blood specimens to academic and commercial researchers worldwide exclusively through Open Biosystems. Conversant's product -
high quality cancer specimens matched with in-depth, privacy-protected clinical information - gives researchers a critical tool in the development of diagnostic tests, prognostic indicators, and targeted therapeutics.
